<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Laser therapy is the optimal approach for treating <z:hpo ids='HP_0001052'>port-wine stains</z:hpo>, but whether it is effective for patients with facial dermatomal <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> and <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> is undetermined </plain></SENT>
<SENT sid="1" pm="."><plain>This project aimed to verify the incidence of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> and <z:hpo ids='HP_0000501'>glaucoma</z:hpo> within the population, compare the response in syndromic and nonsyndromic patients with facial dermatomal <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> to laser, and determine the treatment response in relation to dermatome and color </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The authors retrospectively reviewed 874 patients with facial <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> (203 displayed a dermatomal pattern) </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment and posttreatment photographs were assessed clinically and recorded on a statistically reliable percentage gradient </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> was diagnosed in 30 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Twelve patients had <z:hpo ids='HP_0000501'>glaucoma</z:hpo>, with the <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> involving the ophthalmic (V1) division of the trigeminal nerve </plain></SENT>
<SENT sid="6" pm="."><plain>The highest proportion of patients with <z:hpo ids='HP_0000501'>glaucoma</z:hpo> came from those with involvement of the maxillary (V2) and/or mandibular (V3) division of the trigeminal nerve </plain></SENT>
<SENT sid="7" pm="."><plain>No patients had <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> with V3 <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> alone </plain></SENT>
<SENT sid="8" pm="."><plain>After laser therapy, only 45 percent of syndromal patients and 55 percent of nonsyndromic patients had a satisfactory outcome (&gt;50 percent) in color and size reduction of dermatomal <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The incidence of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> was 3 percent in patients with a facial <z:hpo ids='HP_0001052'>port-wine stain</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>There was an increased risk of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> with involvement of V1 <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> and no risk with involvement of V3 <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> alone </plain></SENT>
<SENT sid="11" pm="."><plain>Laser treatment produced unsatisfactory outcomes in patients with facial dermatomal <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>V3 <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> responded best and V2 worst to laser </plain></SENT>
</text></document>